1345 — Shanghai Pioneer Holding Share Price
- HK$2.84bn
- HK$2.82bn
- CNY1.53bn
- 81
- 57
- 58
- 76
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.4 | ||
Price to Tang. Book | 2.45 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.74 | ||
EV to EBITDA | 10.68 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 18.47% | ||
Return on Equity | 14.32% | ||
Operating Margin | 14.27% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CNYm | 1,332.04 | 1,434.82 | 1,556.04 | 1,566.67 | 1,531.05 | n/a | n/a | 3.07% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -48.62 | +193.11 | +44.62 | -33.45 | +17.37 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Shanghai Pioneer Holding Ltd, formerly China Pioneer Pharma Holdings Ltd, is an investment holding company mainly engaged in the marketing, promotion and sales of pharmaceutical products, medical devices and personal protective equipment. The Company operates mainly through two segments. The Products Sold via the Provision of Channel Management Services segment is principally engaged in the sales of the Company's ophthalmic pharmaceutical products to customers through pipeline management arrangements. The Products Sold via the Provision of Comprehensive Marketing, Promotion and Channel Management Services segment is principally engaged in the sale of all of the Company's pharmaceutical products and medical devices to customers through comprehensive marketing, promotion and channel management arrangements.
Directors
- Xinzhou Li CHM (57)
- Chunyi Luo CEO (50)
- Yi Xue CFO (41)
- Wenfei Huang GMG (45)
- Gang Shi GMG (41)
- Juming Wang GMG (53)
- Tao Wang GMG (44)
- Xiuyan Yang GMG (52)
- Guoguang Xiao EDR (56)
- Weijuan Lai OTH (26)
- Xuefeng Liu OTH (39)
- Jin Shao OTH (38)
- Rongrong Wang OTH (36)
- Ka Man Ng SEC
- Mingfei Hu NED (58)
- Chanshu Lai NID (73)
- Chi Hung Wong NID (40)
- Hong Zhang NID (60)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 5th, 2013
- Public Since
- November 5th, 2013
- No. of Employees
- 335
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,257,447,000

- Address
- No. 15, SHANGHAI, 201201
- Web
- http://www.pioneer-pharma.com/
- Phone
- +86 2150498986
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for 1345
Dividend For 1345.HK - 0.0560 HKD
Similar to 1345
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 23:13 UTC, shares in Shanghai Pioneer Holding are trading at HK$2.26. This share price information is delayed by 15 minutes.
Shares in Shanghai Pioneer Holding last closed at HK$2.26 and the price had moved by +20.21% over the past 365 days. In terms of relative price strength the Shanghai Pioneer Holding share price has outperformed the FTSE Developed Asia Pacific Index by +21.59% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Shanghai Pioneer Holding dividend yield is 4.6% based on the trailing twelve month period.
Last year, Shanghai Pioneer Holding paid a total dividend of CNY0.10, and it currently has a trailing dividend yield of 4.6%.Looking ahead, shares in Shanghai Pioneer Holding are due to go ex-dividend on 2025-06-03 and the next dividend pay date is 2025-06-16.
Shanghai Pioneer Holding are due to go ex-dividend on 2025-06-03 and the next dividend pay date is 2025-06-16. The historic dividend yield on Shanghai Pioneer Holding shares is currently 4.6%.
To buy shares in Shanghai Pioneer Holding you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$2.26, shares in Shanghai Pioneer Holding had a market capitalisation of HK$2.84bn.
Here are the trading details for Shanghai Pioneer Holding:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1345
Based on an overall assessment of its quality, value and momentum Shanghai Pioneer Holding is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shanghai Pioneer Holding. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +15.13%.
As of the last closing price of HK$2.26, shares in Shanghai Pioneer Holding were trading +4.51% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Shanghai Pioneer Holding PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$2.26.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Shanghai Pioneer Holding's management team is headed by:
- Xinzhou Li - CHM
- Chunyi Luo - CEO
- Yi Xue - CFO
- Wenfei Huang - GMG
- Gang Shi - GMG
- Juming Wang - GMG
- Tao Wang - GMG
- Xiuyan Yang - GMG
- Guoguang Xiao - EDR
- Weijuan Lai - OTH
- Xuefeng Liu - OTH
- Jin Shao - OTH
- Rongrong Wang - OTH
- Ka Man Ng - SEC
- Mingfei Hu - NED
- Chanshu Lai - NID
- Chi Hung Wong - NID
- Hong Zhang - NID